0001246360-14-003051.txt : 20140627 0001246360-14-003051.hdr.sgml : 20140627 20140624170708 ACCESSION NUMBER: 0001246360-14-003051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140620 FILED AS OF DATE: 20140624 DATE AS OF CHANGE: 20140624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quart Barry D CENTRAL INDEX KEY: 0001384243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 14938087 MAIL ADDRESS: STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC STREET 2: 1009 OAK HILL ROAD, SUITE 201 CITY: LAFAYETTE STATE: CA ZIP: 94549 4 1 form.xml PRIMARY DOCUMENT X0306 4 2014-06-20 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001384243 Quart Barry D 33 HAYDEN AVE LEXINGTON MA 02421 true false false false Common Stock 2014-06-20 4 M false 1375 25 A 1375 D Common Stock 2014-06-20 4 S false 1375 100 D 0 D Stock Option (Right to Buy) 25 2014-06-20 4 M false 1375 0 D 2017-08-14 Common Stock 1375 0 D The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014. The reporting person previously transferred an option to purchase 1,375 Shares of the original 2,750 granted under this stock option, which transfer was not reported as permitted under Rule 16a-12 of the Securities Exchange Act. The stock option granted the reporting person an option to purchase 2,750 Shares. All of these options vested and first became exercisable on August 14, 2008. These stock options were granted pursuant to the Trimeris, Inc. Amended and Restated Stock Incentive Plan. /s/ Thomas W. Beetham, Attorney-in-Fact 2014-06-24